CD36 and myeloid sarcoma: Two of these, CD32B+ and CD36+ cDC2s (also referred to by others as CD1C_A/DC2 and CD1C_B/DC3, respectively), were previously identified in peripheral blood (24), the former of which we found to be substantially elevated in the CSF of subjects with MS.